AAAAAA

   
Results: 1-7 |
Results: 7
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial
Authors: Mavroudis, D Kourousis, C Androulakis, N Kalbakis, K Agelaki, S Kakolyris, S Souglakos, J Sarra, E Vardakis, N Hatzidaki, D Sarmonis, G Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
Authors: Kakolyris, S Souglakos, J Agelaki, S Kourousis, C Mavroudis, D Sarra, E Malliotakis, P Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
Authors: Mavroudis, D Kourousis, C Kakolyris, S Agelaki, S Kalbakis, K Androulakis, N Souglakos, J Vardakis, N Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
Authors: Mavroudis, D Malamos, N Alexopoulos, A Kourousis, C Agelaki, S Sarra, E Potamianou, A Kosmas, C Rigatos, G Giannakakis, T Kalbakis, K Apostolaki, F Vlachonicolis, J Kakolyris, S Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study
Authors: Androulakis, N Kourousis, C Dimopoulos, MA Samelis, G Kakolyris, S Tsavaris, N Genatas, K Aravantinos, G Papadimitriou, C Karabekios, S Stathopoulos, GP Georgoulias, V
Citation: N. Androulakis et al., Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study, J CL ONCOL, 17(6), 1999, pp. 1779-1785
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin
Authors: Kakolyris, S Kourousis, C Koukourakis, M Androulakis, N Vamvakas, L Agelaki, S Hatzidaki, D Samonis, G Tsiftsis, D Georgoulias, V
Citation: S. Kakolyris et al., First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin, AM J CL ONC, 22(6), 1999, pp. 568-572
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4(+) cell proliferation
Authors: Sara, E Kotsakis, A Souklakos, J Kourousis, C Kakolyris, S Mavromanolakis, E Vlachonicolis, J Georgoulias, V
Citation: E. Sara et al., Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4(+) cell proliferation, ANTICANC R, 19(1A), 1999, pp. 471-476
Risultati: 1-7 |